Tibsovo (ivosidenib) has been granted a major additional benefit rating for its use as a first-line ...
Read moreThe Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...
Read moreThe statutory scheme has been updated with new percentages for 2024-2026, and has received backlash ...
Read moreGermany’s Health minister has announced that publicly listed AMNOG rebates could be replaced by co...
Read moreAIFA reform is a landmark change which propels Italy towards expedited drug approvals and improved a...
Read moreThe MHRA grants conditional approval to Casgevy, the first-ever CRISPR gene-editing therapy for sick...
Read moreGovernment, NHS, and Pharma Industry Unveil Successor to Voluntary Scheme for Branded Medicines Pric...
Read moreGermany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de...
Read moreDiscover the latest developments in AIFA reform as delays persist with the extension of CTS and CPR ...
Read moreSwitzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an...
Read more